A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
NCT06562543
This study is recruiting at 32 US sites in 18 states, according to its ClinicalTrials.gov record last updated .
Summary
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a bigger risk of higher blood pressure after treatment with fruquintinib. The main aim of this study is to learn how often adults of a minority group experience hypertension after they have been treated with fruquintinib for refractory mCRC.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Colorectal Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Takeda
- Last updated on ClinicalTrials.gov
- July 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 2
- Central Alabama Research · Birmingham, AL
- University of Alabama at Birmingham · Birmingham, AL
Arizona · 2
- Ironwood Cancer and Research Centers · Chandler, AZ
- University of Arizona · Tucson, AZ
California · 3
- University of California San Diego · La Jolla, CA
- University of Southern California · Los Angeles, CA
- PIH Health Whittier Hospital · Whittier, CA
Delaware · 1
- Christiana Care Health Services · Newark, DE
Georgia · 1
- Emory University · Atlanta, GA
Illinois · 1
- Hope and Healing Cancer Services · Hinsdale, IL
Indiana · 1
- Indiana University · Indianapolis, IN
Louisiana · 2
- Our Lady of the Lake Physician Group - LSU Health Baton Rouge Oncology · Baton Rouge, LA
- Willis Knighton Cancer Center · Shreveport, LA
Maryland · 1
- Mercy Medical Center · Baltimore, MD
Mississippi · 1
- Hattiesburg Clinic · Hattiesburg, MS
Missouri · 3
- Midwest Oncology Associates - Kansas City · Kansas City, MO
- SSM Health St. Louis DePaul Hospital · St Louis, MO
- Washington University School of Medicine · St Louis, MO
New Jersey · 1
- Capital Health Medical Center - Hopewell · Pennington, NJ
Ohio · 1
- Zangmeister Cancer Center · Columbus, OH
Pennsylvania · 1
- Jefferson Health · Philadelphia, PA
Tennessee · 2
- University of Tennessee -- Memphis · Memphis, TN
- Vanderbilt University Medical Center · Nashville, TN
Texas · 6
- University of Texas Southwestern Medical Center · Dallas, TX
- Renovatio Clinical · El Paso, TX
- Baylor College of Medicine · Houston, TX
- Oncology Consultants - Memorial City Location · Houston, TX
- Renovatio Clinical · The Woodlands, TX
- Tranquil Research · Webster, TX
Virginia · 2
- UC Irvine Medical Center - Chao Family Comprehensive Cancer · Orange, VA
- Virginia Commonwealth University · Richmond, VA
Washington · 1
- Medstar Speciality Hospital · Northwest, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.